Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Whitfield ointment is a topical antifungal and keratolytic medication used to treat fungal skin infections. It is a combination of benzoic acid and salicylic acid, typically in a ratio of 2:1 (such as 6% benzoic acid and 3% salicylic acid). Benzoic acid provides fungistatic properties, inhibiting the growth of fungi, while salicylic acid acts as a keratolytic agent, promoting the desquamation of the stratum corneum to facilitate the penetration of the antifungal component. It is commonly indicated for conditions such as tinea pedis (athlete's foot), tinea corporis (ringworm), and tinea cruris (jock itch). Praise Pharma manufactures this product as a marketed generic pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzoic acid + salicylic acid.